Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
Mydecine Innovations Announces Amended Press Release Relating to the Closing of Prospectus Supplement Financing
Revolve Receives Approval from the Alberta Utilities Commission for the 15.7 MW Bright Meadows Solar Project
Silver47 Announces Closing of $23 Million Brokered LIFE Financing, Including Full Exercise of the Over-Allotment Option
FPX Nickel Announces Funding Contribution from Natural Resources Canada to Advance the Baptiste Nickel Project